Chimerix (CMRX) PT Lowered to $2 at Citi
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Citi analyst Yigal Nochomovitz lowered the price target on Chimerix (NASDAQ: CMRX) to $2.00 (from $4.25) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FirstRand Ltd. (FSR:SJ) (FANDF) PT Raised to ZAR73 at HSBC
- China Education Group Holdings Ltd. (839:HK) PT Lowered to HK$18.50 at CLSA
- APA Group (APA:AU) (APAJF) PT Lowered to AUD8.80 at Credit Suisse
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!